See below for the latest Centers for Disease Control and Prevention guidance and recommendations for hospital and health system leaders during the COVID-19 pandemic.
This page highlights resources identified or developed to address current response and recovery operations to novel coronavirus 2019 (COVID-19).
CDC checklist highlights important areas for hospitals to ensure staff are trained, equipped and capable of identifying and caring for COVID-19 patients and preventing the spread of COVID-19 within the facility
Get tips, links and essential information to improve safety during the COVID-19 outbreak.
FAQs and considerations for patient triage, placement and hospital discharge.
March 24 AHA Advisory
In this AHA Advisory, the CDC clarified that patients with COVID-19 can be discharged from a health care facility when clinically indicated.
March 23 AHA Advisory
CMS Will Only Conduct Certain Surveys During COVID-19 Enforcement Discretion Period. In this AHA Advisory, CMS will prioritize and conduct only certain surveys during the COVID-19 national emergency’s three-week enforcement discretion period, the agency has announced.
March 23 AHA Advisory
In this AHA Advisory, we share the latest information from FDA focused on mitigating disruptions to or shortages in the ventilator supply chain. The agency released updated guidance to provide flexibility around and expand the availability of ventilators and other respiratory devices to treat patients during the public health emergency.
March 22 AHA Advisory
In this AHA Advisory, we share the latest CMS information regarding a range of data reporting exceptions it recently announced and extensions across its quality reporting and value-based payment programs for hospitals, post-acute care facilities and clinicians. March 22, 2020. (CMS) announced today it is granting a range of data reporting exceptions and extensions across its quality reporting and value-based payment programs for hospitals, post-acute care facilities and clinicians.
The CDC released new guidance for retirement communities and independent living facilities to better aid in the planning, preparation for, and response to coronavirus disease 2019. The guidance is based on what is currently known about the transmission and severity of coronavirus disease. Residents in retirement communities and independent living facilities are considered to be at higher risk of severe COVID-19 outcomes because of older age and because they may have underlying health conditions. These resources can be accessed using the links below.
March 11 AHA Advisory
CMS and the Internal Revenue Service (IRS) have released a number of new documents related to COVID-19. This includes: Emergency Medical Treatment and Labor Act (EMTALA) requirements; Medicare Advantage (MA) and Part D requirements and flexibilities; cost-sharing for high-deductible health plans; respirator and facemask use for health care workers; and health and safety for home health agency (HHA) and dialysis providers.
March 10 Headline Item
March 9 Headline Item
Updated guidance for evaluating and testing patients for novel coronavirus (COVID-19), and for assessing and managing health care personnel with potential exposure to patients with the virus
March 7 CDC Guidance
March 7 CDC Guidance
Updated recommendations for health care personnel.
March 5 Advisory
The Senate March 5 passed an $8.3 billion spending package to combat the novel coronavirus (COVID-19). The House overwhelmingly passed the package March 4. Among other items the package includes $300 million for hospital and health systems’ efforts to prepare for and respond to COVID-19.
March 5 Headline Item
March 3 Advisory
Brief description and links to the CDC documents, including tips for consumers, and other COVID-19 updates
March 2 Headline Item
Early news from Washington state and CDC’s response.
Policy for Diagnostics Testing in Laboratories Certified to Perform High Complexity Testing under CLIA prior to Emergency Use Authorization for Coronavirus Disease-2019 during the Public Health Emergency Immediately in Effect Guidance for Clinical Laboratories and Food and Drug Administration Staff
Feb. 29 FDA guidance
This Food and Drug Administration guidance provides a policy for novel coronavirus (COVID-19) molecular diagnostics tests developed and used in laboratories certified to perform high-complexity testing under the Clinical Laboratory Improvement Amendments (CLIA) prior to issuance of emergency use authorizations (EUA) for such tests.
This interim guidance outlines goals and strategies for all U.S. health care facilities to prepare for and respond to community spread of COVID-19.
Feb 20 Listening Session
More CDC Resources
The Community Healthcare Decision Pathway provides an algorithm for community and health care leaders and other decision makers to assess resource availability and medical surge at the health care and community levels.